About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.63 (-9.00%)
NERV NASDAQ Minerva Neurosciences Inc
Minerva Neurosciences Inc share price
NERV price activity
Last Price
$2.630
Change (24hr)
-0.26 USD (-9.00%)
Volume
69.76K
Volume (4w avg)
-
Open
$2.88
Day Range
$2.63 - $2.88
Previous Close
$2.89
Last Trade
13 Oct, 4:36 pm GMT+0
Delayed
13 Oct, 4:36 pm GMT+0
NERV price performance
Delayed
13 Oct, 4:36 pm GMT+0
NERV Market Signals